Catalyst Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 11/12/2025 | 18.22 M | $358.86 M | -3.62% | 14.91% |
| VANGUARD GROUP INC | 11/07/2025 | 8.71 M | $171.66 M | -0.60% | 7.13% |
| STATE STREET CORP | 11/14/2025 | 6.41 M | $126.19 M | 16.92% | 5.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 11/14/2025 | 4.97 M | $98.00 M | 72.77% | 4.07% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 3.54 M | $69.83 M | 9.02% | 2.90% |
| FUNDSMITH LLP | 11/14/2025 | 3.36 M | $66.27 M | 24.17% | 2.75% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 2.89 M | $56.95 M | 0.82% | 2.37% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2025 | 2.53 M | $49.81 M | 43.81% | 2.07% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 2.46 M | $48.42 M | 28.87% | 2.01% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 2.29 M | $45.14 M | -3.14% | 1.88% |
| ROYCE & ASSOCIATES LP | 11/12/2025 | 2.03 M | $40.09 M | 28.56% | 1.67% |
| MORGAN STANLEY | 11/14/2025 | 1.84 M | $36.32 M | -42.09% | 1.51% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 1.33 M | $26.24 M | -7.25% | 1.09% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 11/13/2025 | 1.30 M | $25.70 M | 6.63% | 1.07% |
| BOSTON PARTNERS | 11/13/2025 | 1.29 M | $25.58 M | 0.65% | 1.06% |
| NORTHERN TRUST CORP | 11/14/2025 | 1.26 M | $24.90 M | -0.88% | 1.03% |
| INVESCO LTD. | 11/13/2025 | 1.23 M | $24.30 M | 1.61% | 1.01% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 1.18 M | $23.23 M | 174.15% | 0.97% |
| KENNEDY CAPITAL MANAGEMENT LLC | 11/13/2025 | 1.06 M | $20.89 M | 5.03% | 0.87% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 1.01 M | $19.84 M | -58.23% | 0.82% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2025 | 821.20 K | $16.18 M | -19.05% | 0.67% |
| ALLIANZ ASSET MANAGEMENT GMBH | 11/04/2025 | 797.95 K | $15.72 M | -23.11% | 0.65% |
| LEGAL & GENERAL GROUP PLC | 11/13/2025 | 774.10 K | $15.25 M | 16.65% | 0.63% |
| RAYMOND JAMES FINANCIAL INC | 11/14/2025 | 773.33 K | $15.23 M | -8.49% | 0.63% |
| MACQUARIE GROUP LTD | 11/13/2025 | 761.74 K | $15.01 M | -15.86% | 0.62% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2025 | 743.68 K | $14.65 M | 1.08% | 0.61% |
| METLIFE INVESTMENT MANAGEMENT, LLC | 11/13/2025 | 739.67 K | $14.57 M | 26.93% | 0.61% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 703.94 K | $13.87 M | -2.20% | 0.58% |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 11/13/2025 | 685.66 K | $13.51 M | 252.29% | 0.56% |
| GLENMEDE INVESTMENT MANAGEMENT, LP | 11/13/2025 | 680.22 K | $13.40 M | 781.80% | 0.56% |
| PRINCIPAL FINANCIAL GROUP INC | 11/04/2025 | 639.12 K | $12.59 M | 2.43% | 0.52% |
| ABRDN PLC | 11/07/2025 | 632.44 K | $12.46 M | -8.18% | 0.52% |
| PACER ADVISORS, INC. | 10/15/2025 | 620.80 K | $12.23 M | -3.77% | 0.51% |
| SWEDBANK AB | 10/15/2025 | 616.13 K | $12.14 M | 0.00% | 0.50% |
| UBS GROUP AG | 11/13/2025 | 593.61 K | $11.69 M | -29.73% | 0.49% |
| JANUS HENDERSON GROUP PLC | 11/14/2025 | 572.20 K | $11.27 M | -23.87% | 0.47% |
| LSV ASSET MANAGEMENT | 11/06/2025 | 552.40 K | $10.88 M | -4.38% | 0.45% |
| NUVEEN, LLC | 11/12/2025 | 542.23 K | $10.68 M | -45.02% | 0.44% |
| OBERWEIS ASSET MANAGEMENT INC/ | 11/17/2025 | 528.56 K | $10.41 M | 12.89% | 0.43% |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 11/06/2025 | 516.75 K | $10.18 M | 10.79% | 0.42% |
| MAN GROUP PLC | 11/14/2025 | 464.00 K | $9.14 M | 7.68% | 0.38% |
| VOYA INVESTMENT MANAGEMENT LLC | 10/09/2025 | 446.40 K | $8.79 M | 25.08% | 0.37% |
| GABLES CAPITAL MANAGEMENT INC. | 11/06/2025 | 435.42 K | $8.58 M | 6.45% | 0.36% |
| VICTORY CAPITAL MANAGEMENT INC | 11/12/2025 | 417.51 K | $8.22 M | 23.96% | 0.34% |
| PRUDENTIAL FINANCIAL INC | 11/13/2025 | 402.79 K | $7.94 M | 7.02% | 0.33% |
| JUPITER ASSET MANAGEMENT LTD | 11/10/2025 | 401.09 K | $7.90 M | -22.52% | 0.33% |
| CITADEL ADVISORS LLC | 11/14/2025 | 397.90 K | $7.84 M | 53.04% | 0.33% |
| FEDERATED HERMES, INC. | 11/03/2025 | 389.29 K | $7.67 M | 52.79% | 0.32% |
| JW ASSET MANAGEMENT, LLC | 11/07/2025 | 388.39 K | $7.65 M | 0.00% | 0.32% |
| JPMORGAN CHASE & CO | 11/26/2025 | 378.81 K | $7.46 M | -12.66% | 0.31% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Catalyst Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 474 institutional investors and hedge funds held shares of Catalyst Pharmaceuticals, Inc.. The most heavily invested institutionals were:
BlackRock, Inc.: 18.22 M
VANGUARD GROUP INC: 8.71 M
STATE STREET CORP: 6.41 M
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C): 4.97 M
RENAISSANCE TECHNOLOGIES LLC: 3.54 M
Fundsmith LLP: 3.36 M
84.54% of Catalyst Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 127.56 M shares in the last 24 months. This purchase volume represents approximately $2.66 B in transactions.